DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
54 hedge funds and large institutions have $313M invested in Dicerna Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
Holders
54
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$23.3M | |
| 2 | +$4.69M | |
| 3 | +$2.96M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.55M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.51M |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$3M | |
| 3 | -$2.91M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$2.6M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.57M |